ONESOURCE SPECIALTY PHARMA
Back to Income Statement
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹-391 Cr | ₹-800 Cr | ₹-231 Cr | ₹-231 Cr |
What is the latest Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-391 Cr |
| Mar2024 | ₹-800 Cr |
| Mar2023 | ₹-231 Cr |
| Mar2022 | ₹-231 Cr |
How is Consolidated Net Profit of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-391 Cr | Negative | |
| Mar2024 | ₹-800 Cr | Negative | |
| Mar2023 | ₹-231 Cr | Negative | |
| Mar2022 | ₹-231 Cr | - | |
Compare Consolidated Net Profit of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹19,379.7 Cr | 2.5% | 9% | -17.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 2.5% |
9% |
-17.1% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses